COVID-19 disease.The launch is part of a global licensing agreement with Fujifilm Toyama Chemical that grants Dr Reddy's exclusive rights to manufacture, sell and distribute Avigan tablets in India.
Avigan has been approved by the Drugs Controller General of India."We are pleased to bring this important innovator medicine to the patients in India.